A groundbreaking “NanoKnife” operation has been developed to help fight prostate cancer. Developed by AngioDynamics, the procedure uses electrical pulses guided by MRI scanning to eradicate hard-to-reach tumors, delicately opening cell membranes and reducing the risk of damage to surrounding tissues.

Traditional treatments for prostate cancer involve radiotherapy or removal surgery, often resulting in complications. The NanoKnife therapy offers greater efficiency and could soon be used as an alternative treatment option by the UK’s NHS.

The NanoKnife trials saw six successful operations performed by surgeons from University College London Hospital (UCLH), who praised the treatment’s simplicity and speed. It is now thought that in the future, overnight hospital stays could be eliminated, reducing strain on healthcare systems.

UCLH consultant urologist Mark Emberton said: “We are delighted to have been the first hospital in the NHS to use irreversible electroporation for patients with prostate cancer. And at times like this, when the NHS is under great pressure, day surgery avoids the need for overnight stays in hospital and means that we can use our operating theaters more efficiently”.

Meanwhile, Neil Gershon, one of the recipients of NanoKnife therapy, added, “It was completed in a day, which was fantastic. After the effects of the general anesthesia subsided, I felt perfectly fine, with no discomfort. It couldn’t have gone any smoother”.

Also Read: Google Is Developing An AI Cancer-Spotting Microscope

According to experts, early studies indicate that NanoKnife and similar focal therapies could revolutionize prostate cancer treatment by attacking tumors with unparalleled accuracy. However, the road to widespread adoption depends on the success of more extensive clinical trials.

For the 50,000+ men diagnosed with prostate cancer each year, this new procedure offers a beacon of hope, with swift, effective, and minimally invasive operations redefining the standard of cancer treatment and care.